291 related articles for article (PubMed ID: 35330147)
21. The kidney is a major site of alpha(2)-antiplasmin production.
Menoud PA; Sappino N; Boudal-Khoshbeen M; Vassalli JD; Sappino AP
J Clin Invest; 1996 Jun; 97(11):2478-84. PubMed ID: 8647939
[TBL] [Abstract][Full Text] [Related]
22. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
[TBL] [Abstract][Full Text] [Related]
23. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
Christensen U; Bangert K; Thorsen S
FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
[TBL] [Abstract][Full Text] [Related]
24. Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.
de Giorgio-Miller A; Bottoms S; Laurent G; Carmeliet P; Herrick S
Am J Pathol; 2005 Sep; 167(3):721-32. PubMed ID: 16127152
[TBL] [Abstract][Full Text] [Related]
25. Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes.
Bryk AH; Siudut J; Broniatowska E; Bagoly Z; Baráth B; Katona É; Undas A
Thromb Res; 2020 Jan; 185():55-62. PubMed ID: 31770688
[TBL] [Abstract][Full Text] [Related]
26. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
[TBL] [Abstract][Full Text] [Related]
27. Protein regions important for plasminogen activation and inactivation of alpha2-antiplasmin in the surface protease Pla of Yersinia pestis.
Kukkonen M; Lähteenmäki K; Suomalainen M; Kalkkinen N; Emödy L; Lång H; Korhonen TK
Mol Microbiol; 2001 Jun; 40(5):1097-111. PubMed ID: 11401715
[TBL] [Abstract][Full Text] [Related]
28. Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.
Ledein L; Léger B; Dees C; Beyer C; Distler A; Vettori S; Boukaiba R; Bidouard JP; Schaefer M; Pernerstorfer J; Ruetten H; Jagerschmidt A; Janiak P; Distler JHW; Distler O; Illiano S
Br J Pharmacol; 2020 Sep; 177(18):4296-4309. PubMed ID: 32627178
[TBL] [Abstract][Full Text] [Related]
29. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
30. Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production.
Okada K; Ueshima S; Kawao N; Yano M; Tamura Y; Tanaka M; Sakamoto A; Hatano M; Arima M; Miyata S; Nagai N; Tokuhisa T; Matsuo O
Life Sci; 2013 Jul; 93(2-3):89-95. PubMed ID: 23770230
[TBL] [Abstract][Full Text] [Related]
31. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
32. α₂-Antiplasmin is involved in bone loss induced by ovariectomy in mice.
Shiomi A; Kawao N; Yano M; Okada K; Tamura Y; Okumoto K; Matsuo O; Akagi M; Kaji H
Bone; 2015 Oct; 79():233-41. PubMed ID: 26094563
[TBL] [Abstract][Full Text] [Related]
33. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
34. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
35. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
36. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
37. X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.
Law RH; Sofian T; Kan WT; Horvath AJ; Hitchen CR; Langendorf CG; Buckle AM; Whisstock JC; Coughlin PB
Blood; 2008 Feb; 111(4):2049-52. PubMed ID: 18063751
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
Weir B; Gordon P
J Neurosurg; 1983 Feb; 58(2):242-5. PubMed ID: 6848682
[TBL] [Abstract][Full Text] [Related]
39. The fibrinolysis inhibitor α
Paquet-Fifield S; Roufail S; Zhang YF; Sofian T; Byrne DJ; Coughlin PB; Fox SB; Stacker SA; Achen MG
Growth Factors; 2017 Jun; 35(2-3):61-75. PubMed ID: 28697634
[TBL] [Abstract][Full Text] [Related]
40. α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responses.
Kanno Y; Miyashita M; Seishima M; Matsuo O
Immun Inflamm Dis; 2020 Sep; 8(3):267-278. PubMed ID: 32237065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
